Latest Tremelimumab Stories

2008-09-16 12:00:49

Bristol-Myers Squibb Company and Medarex have announced updated survival data from three Phase II studies of ipilimumab in patients with advanced metastatic melanoma who had previously been treated.

2008-09-08 18:00:09

Pfizer announced today that important study results involving the company's leading anticancer agent, SUTENT(R) (sunitinib malate), as well as data examining an investigational agent, CP-751,871, will be presented at the 33rd European Society for Medical Oncology (ESMO) Congress in Stockholm, 12--16 September 2008.

2008-08-15 09:01:04

Oncolytics Biotech has announced that the US National Cancer Institute, part of the National Institutes of Health, has started enrollment in a Phase II clinical trial for patients with metastatic melanoma using systemic administration of Reolysin, Oncolytics's proprietary formulation of the human reovirus.

Word of the Day
  • To say in too many words; to express verbosely.
  • To express in too many words: sometimes used reflexively.
  • The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.
The word 'overword' comes from over- +‎ word.